Literature DB >> 11294852

Cloning and characterization of the 5'-flanking region of the human transcription factor Sp1 gene.

M Nicolás1, V Noé, K B Jensen, C J Ciudad.   

Abstract

The 5'-flanking region of the human Sp1 gene was cloned and characterized. Sequence analysis of this region showed the absence of both CAAT and TATA boxes and an initiator element. The proximal promoter of the Sp1 gene is a GC-rich region that contains multiple GC boxes and Ap2 binding sites. The major transcription start site is located 63 base pairs upstream of the translation start site. Transfection experiments demonstrate that all the elements necessary to achieve significant basal transcription activity are located between positions -443 and -20 relative to the translational start. Sp1 and Sp3 proteins bind to the downstream GC box located in the proximal promoter of Sp1. Furthermore, we demonstrate that the Sp1 protein activates Sp1 transcription activity; thus the Sp1 gene is autoregulated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294852     DOI: 10.1074/jbc.M010740200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.

Authors:  Marta Nicolás; Vèronique Noé; Carlos J Ciudad
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

2.  Curcumin decreases specificity protein expression in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sudhakar Chintharlapalli; Sabitha Papineni; Roger Smith; Xiangrong Li; Stephen Safe
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

3.  High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma.

Authors:  Yi-Ting Chen; Hung-Pei Tsai; Chun-Chieh Wu; Chiao-Yun Chen; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Pathol Oncol Res       Date:  2018-06-09       Impact factor: 3.201

4.  Bortezomib Targets Sp Transcription Factors in Cancer Cells.

Authors:  Keshav Karki; Sneha Harishchandra; Stephen Safe
Journal:  Mol Pharmacol       Date:  2018-08-16       Impact factor: 4.436

5.  Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.

Authors:  Seung Kyoon Woo; Min Seong Kwon; Zhihua Geng; Zheng Chen; Alexander Ivanov; Sergei Bhatta; Volodymyr Gerzanich; J Marc Simard
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

6.  Regulation of Sp1 by cell cycle related proteins.

Authors:  Alicia Tapias; Carlos J Ciudad; Igor B Roninson; Véronique Noé
Journal:  Cell Cycle       Date:  2008-09-24       Impact factor: 4.534

7.  Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells.

Authors:  Im-Sook Song; Helen H W Chen; Isamu Aiba; Anwar Hossain; Zheng D Liang; Leo W J Klomp; Macus Tien Kuo
Journal:  Mol Pharmacol       Date:  2008-05-15       Impact factor: 4.436

8.  Cystathionine β-synthase regulates endothelial function via protein S-sulfhydration.

Authors:  Sounik Saha; Prabir K Chakraborty; Xunhao Xiong; Shailendra Kumar Dhar Dwivedi; Soumyajit Banerjee Mustafi; Noah R Leigh; Ramani Ramchandran; Priyabrata Mukherjee; Resham Bhattacharya
Journal:  FASEB J       Date:  2015-09-24       Impact factor: 5.191

9.  DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy.

Authors:  Marjan M Tajrishi; Jonghyun Shin; Michal Hetman; Ashok Kumar
Journal:  J Biol Chem       Date:  2014-06-03       Impact factor: 5.157

10.  Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition.

Authors:  Emmanuelle Deniaud; Joël Baguet; Roxane Chalard; Bariza Blanquier; Lilia Brinza; Julien Meunier; Marie-Cécile Michallet; Aurélie Laugraud; Claudette Ah-Soon; Anne Wierinckx; Marc Castellazzi; Joël Lachuer; Christian Gautier; Jacqueline Marvel; Yann Leverrier
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.